Pulmonary hypertension (PH) is a rare, life-threatening disease affecting the arteries of the lungs that can lead to right heart failure. Pulmonary hypertension (PH) is a rare, chronic illness of the lungs that affects the functioning of the heart and can lead to right heart failure. While there’s currently no cure, there are 16 FDA-approved therapies available to help patients live better lives.
Without treatment, mean survivability is only 2.8 years. OUR APPROACH
phaware is devoted to elevating our mission by making the public, news media, donors and investors of pulmonary hypertension. phaware ignites the global conversation and heightens PH awareness in unprecedented ways. Our prime directive is to capture, engage and enable diagnosed and undiagnosed PH patients, caregivers, and medical professions by providing them with digital content focused on education, resources and knowledge. Join the global conversation. Become . Follow us on Facebook, Twitter, Instagram, Pinterest & Vine. Get the phaware mobile app (on the Apple and Google Play app store). phaware® is a 501(c)3 organization. © Copyright 2015. All Rights Reserved. Sponsorship support provided by Actelion Pharmaceuticals US, Inc. and by Bayer
The views and opinions expressed in the phaware™ podcast do not necessarily reflect the official policy or position of phaware global association. Information on phaware.global and phaware social media sites is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.